|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.000 USD | -2.44% |
|
-.--% | +46.28% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -100.91x | 9.17x | 0.29x | 20.77x | 51.72x | -84.3x | -.--% | 55.21B | |
| 37.55x | 4.09x | 0.49x | 2.87x | 22.75x | 36.53x | 1.17% | 4.18B | |
| 94.14x | 6.11x | 1.36x | 12.06x | 18.8x | 111.64x | 0.27% | 3.2B | |
| 36.1x | 13.14x | 2.32x | 11.3x | 24.46x | 28.11x | 1.89% | 2.08B | |
| -25.31x | 3.66x | 0.44x | - | - | - | 0.1% | 1.24B | |
| 41.48x | 8.4x | 1.3x | 17.11x | 26.56x | 29.14x | 0.56% | 1.23B | |
| 26.75x | 2.2x | 2.87x | 3.61x | 14.42x | 18.71x | 0.67% | 1.23B | |
| 14.74x | 4.35x | 0.37x | - | - | - | 0.39% | 1.1B | |
| -2.05x | - | 0.26x | 5.14x | 8.4x | 97.09x | -.--% | 556M | |
| 25.25x | 3.2x | 1.5x | 2.77x | 8.15x | 12.99x | - | 163M | |
| -55.16x | 4.49x | 0.62x | 1.48x | 11.43x | -37.53x | - | 120M | |
| 23.56x | 5.3x | -1.23x | 0.88x | 10.33x | 13.25x | -.--% | 64.47M | |
| Average | 9.68x | 5.83x | 0.88x | 7.80x | 19.70x | 22.56x | 0.51% | 5.86B | |
| Weighted average by Cap. | -70.65x | 8.51x | 0.48x | 18.37x | 45.86x | -58.42x | 0.17% |
- Stock Market
- Stocks
- DXRX Stock
- DIUXF Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
